MedPath
HSA Approval

MO-FLOREN OPHTHALMIC SOLUTION 0.5% USP

SIN14899P

MO-FLOREN OPHTHALMIC SOLUTION 0.5% USP

MO-FLOREN OPHTHALMIC SOLUTION 0.5% USP

December 1, 2015

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01AE07

moxifloxacin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Indoco Remedies Limited

Active Ingredients

Moxifloxacin Hydrochloride 5.45mg/ml eqv Moxifloxacin

5mg/ml

Moxifloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MO-FLOREN OPHTHALMIC SOLUTION 0.5% USP - HSA Approval | MedPath